Open

ASCENDR Research Grant Program – 2026 Cycle

Institutionally Coordinated // Limit: 2 // Tickets Available: 2

This opportunity is being institutionally coordinated by Research Development Services and the Office of Hispanic Serving Institution Initiatives. If you are interested, please contact Riley McIssac and Cody Nicholls.

Limiting Language
Limit on number of proposals per university: 2

About ASCENDR
ASCENDR Research is a competitively funded DOD research program that is aligned to the U.S. National Defense Science and Technology Strategy and the DOD Critical Technology Areas and part of the HSRU’s Advancing STEM Careers through Education, Networking, Development + Research (ASCENDR) Initiative (for more information about ASCENDR visit www.hsru.org) For this opportunity, research priority areas are: Advanced Materials, Human-Machine Interfaces, and Space Technology. Through this competitively funded research program, HSRU Alliance member institutions’ research strengths will be leveraged, faculty leadership development will be provided, and graduate student researchers will be integrated. This research program will have the aims to (1) expose both faculty and students to military operations and defense and national security real-world challenges, (2) deploy and enhance the research environments conducive for the successful progression and participation of the students in the process (e.g. mentoring, professional development, and financial support), and to (3) conduct research and deliver research outcomes to meet DOD technical challenges/gaps.


 

Funding Type
Internal Deadline
External Deadline
2/27/2026

Data.org Activate AI: Economic Opportunity Challenge

Notify Limited Submissions of Your Intent to Submit a Proposal  Please include a brief summary of the planned project scope // Limit: Must notify if there are two or more planned institutional proposals

Limiting Language
Organizations are limited to submitting one Entry to the Challenge. Notwithstanding the foregoing, the Challenge may consider multiple Entries from large organizations such as universities. Any such Entries must be distinct, without overlap in the scope of the proposals or the project teams. If you are aware that two or more teams within your organization are submitting Entries to the Challenge, please notify us by email at challenge@data.org and include an explanation as to how your team meets the foregoing requirement.

Funding Highlights
The Activate AI: Economic Opportunity Challenge is a global call for innovative AI applications that empower people and communities, and that unlock economic opportunity for a resilient future. With the launch of this challenge, data.org and Zoom are seeking out projects that drive AI workforce development and organizational capacity, develop pathways to create future friendly jobs leveraging data and AI, and build climate resilient communities for a green economy. 

Sponsor Notes
The Challenge will award at least five final winners with a combination of grant funding and in-kind support with a combined total value of $115,000 USD. In-kind support may include, but is not limited to, data science talent, staff training, technical support and consulting, media production, marketing and promotional outreach, and software and infrastructure licenses. 

Internal Deadline
External Deadline
1/8/2026
Solicitation Type

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) - February 2026 Deadline

Limit: 4* (see below) // Tickets Available: 3

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 0
​J. Llavona-Ortiz (Cancer Center) 

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."
Funding Type
Internal Deadline
External Deadline
2/17/2026
Solicitation Type

Recordings at Risk - Thirteenth Cycle (Feb 2026 Deadline)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicant organizations may submit only one application per cycle.

Program Overview
Recordings at Risk is a national regranting program administered by CLIR to support the preservation of rare and unique audio, audiovisual, and other time-based media of public value through digital reformatting. 

Eligible media may include but are not necessarily limited to, magnetic audio and video tape, grooved discs, wax cylinders, wire recordings, and film (with or without sound).

Recordings at Risk encourages professionals who may be constrained by limited resources and/or technical expertise to take action against the threats of degradation and obsolescence. The program aims to help organizations identify priorities and develop practical strategies for digital reformatting, build relationships with partners, and raise awareness of best practices.

Research Category
Funding Type
Internal Deadline
External Deadline
2/24/2026

St. Baldrick's Foundation 2026 Summer Fellowship Awards

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Institutions may submit only one (1) new Summer Fellow application per year. 

Program Overview
St. Baldrick's offers Summer Fellowship Awards, funding stipends for undergraduate, graduate, or medical school students to work in a pediatric oncology setting for a summer. The total award, paid to the mentor's institution, is $5,000.

Funding Type
Internal Deadline
External Deadline
2/20/2026
Solicitation Type

Rediscovering Our Revolutionary Tradition - January 2026 Deadline

No Applicants // Limit: 1 // Tickets Available: 1 

Limiting Language
An organization may submit one application per deadline under this notice. 

Executive Summary
The National Endowment for the Humanities (NEH) Division of Preservation and Access is accepting applications for the Rediscovering Our Revolutionary Tradition program. The purpose of this program is to preserve and improve access to primary source materials that document the history of America’s founding era and of American government in federal, state, and local contexts. Supported activities include conservation treatment and rehousing, digitization and description, transcription and translation, and updating existing digital resources to ensure longterm public availability. This program is offered in honor of the 250th anniversary of the signing of the Declaration of Independence in 2026.

Research Category
Funding Type
Internal Deadline
External Deadline
1/15/2026

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) - June 2025 Deadline

No Applicants // Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. An individual may not have two or more competing NIH career development applications pending review concurrently. In addition, NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review. (See NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."


 

Funding Type
Internal Deadline
External Deadline
6/16/2025
Solicitation Type